The boosting effect of minoxidil 0.1% when combined with dutasteride 0.01% and microneedling in the treatment of female pattern hair loss

被引:0
|
作者
Essam, Reham [1 ]
Selim, Heba [1 ]
Ehab, Rana [1 ]
机构
[1] Zagazig Univ, Dept Dermatol Venereol & Androl, Fac Med, Zagazig, Egypt
来源
JOURNAL OF EGYPTIAN WOMENS DERMATOLOGICAL SOCIETY | 2024年 / 21卷 / 01期
关键词
dutasteride; female pattern hair loss; microneedling; minoxidil; trichoscopy;
D O I
10.4103/jewd.jewd_35_23
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Female pattern hair loss (FPHL) is a disease characterized by progressive hair thinning. Topical minoxidil is an FDA-approved drug for the treatment of androgenetic alopecia. Dutasteride (a 5 alpha-reductase inhibitor) can also be used in a topical form to reduce its systemic side effects. Both agents can be used as mesotherapy after microneedling of the scalp to enhance their potency in the treatment of FPHL. Objective To compare the use of combined minoxidil and dutasteride versus dutasteride alone when applied topically after microneedling of the scalp in the treatment of FPHL. Patients and methods This study included 40 female patients with FPHL. Patients were divided into two groups: one group was treated with combined minoxidil 0.1% and dutasteride 0.01% with microneedling, and the other group received dutasteride 0.01% alone with microneedling. Trichoscopic evaluation was done. Results In a group A, who were treated with combined minoxidil and dutasteride, 4 patients (20%) had excellent improvement, 10 patients (50%) had a good response, 5 patients (25%) had a moderate response, and only 1 patient (5%) had no response, while in a group B, who treated with dutasteride, 1 patient (5%) had excellent improvement, 4 patients (20%) had a good response, 10 patients (50%) had a moderate response, and 5patients(25%) had no response, with a significant difference between both groups (P=0.033. There were the nonsignificant difference between both groups regarding trichoscopic findings before treatment, but after treatment, there was a significant difference between both groups concerning the mean percentage of the follicular unit with one hair and the number of patients who had vellus hairs in the dermoscopic field. Conclusion The combination of minoxidil 0.1% and dutasteride 0.01% after microneedling of the scalp was significantly more effective than dutasteride alone with microneedling for the treatment of FPHL.
引用
收藏
页码:29 / 35
页数:7
相关论文
共 50 条
  • [11] Efficacy of 5% minoxidil versus combined 5% minoxidil and 0.01% tretinoin for male pattern hair loss - A randomized, double-blind, comparative clinical trial
    Shin, Hyo Seung
    Won, Chong Hyun
    Lee, Seung Ho
    Kwon, Oh Sang
    Kim, Kyu Han
    Eun, Hee Chul
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2007, 8 (05) : 285 - 290
  • [12] A clinical study on the efficacy of minoxidil liniment in treating female pattern hair loss
    Chen, Bin
    Gao, An-qiong
    Yao, Shuang
    Liu, Ya-yuan
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2023, 22 (12) : 2483 - 2488
  • [13] Sulfotransferase activity in plucked hair follicles predicts response to topical minoxidil treatment in Brazilian female pattern hair loss patients
    Ramos, Paulo Mueller
    Sinclair, Rodney
    Miot, Helio Amante
    Goren, Andy
    DERMATOLOGIC THERAPY, 2020, 33 (01)
  • [14] Spironolactone for treatment of female pattern hair loss
    Burns, Laura J.
    De Souza, Brianna
    Flynn, Elizabeth
    Hagigeorges, Dina
    Senna, Maryanne M.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (01) : 276 - 278
  • [15] Finasteride treatment of female pattern hair loss
    Iorizzo, M
    Vincenzi, C
    Voudouris, S
    Piraccini, BM
    Tosti, A
    ARCHIVES OF DERMATOLOGY, 2006, 142 (03) : 298 - 302
  • [16] Treatment of male and female pattern hair loss with sublingual minoxidil: a retrospective case-series of 64 patients
    Sinclair, R.
    de Carvalho, L. Trindade
    Ismail, F. Ferial
    Meah, N.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2020, 34 (12) : E795 - E796
  • [17] Quality of life in women with female pattern hair loss and the impact of topical minoxidil treatment on quality of life in these patients
    Zhuang, Xiao-Sheng
    Zheng, You-You
    Xu, Jia-Jia
    Fan, Wei-Xin
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2013, 6 (02) : 542 - 546
  • [18] Efficacy and Safety of 5% Minoxidil Alone, Minoxidil Plus Oral Spironolactone, and Minoxidil Plus Microneedling on Female Pattern Hair Loss: A Prospective, Single-Center, Parallel-Group, Evaluator Blinded, Randomized Trial
    Liang, Xuelei
    Chang, Yuan
    Wu, Haixuan
    Liu, Yi
    Zhao, Jian
    Wang, Leyi
    Zhuo, Fenglin
    FRONTIERS IN MEDICINE, 2022, 9
  • [19] Minoxidil 1 mg oral versus minoxidil 5% topical solution for the treatment of female-pattern hair loss: A randomized clinical trial
    Ramos, Paulo Mueller
    Sinclair, Rodney D.
    Kasprzak, Michal
    Miot, Helio Amante
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 82 (01) : 252 - 253
  • [20] Minoxidil Sulfotransferase Enzyme (SULT1A1) genetic variants predicts response to oral minoxidil treatment for female pattern hair loss
    Ramos, P. M.
    Gohad, P.
    Mccoy, J.
    Wambier, C.
    Goren, A.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (01) : E24 - E26